Holds 2 active US DMFs and one valid CEP for itraconazole, filing since 2012. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for itraconazole, filing since 2025. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for itraconazole, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 4 valid CEPs for itraconazole, filing since 2023. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF and one valid CEP for itraconazole, filing since 2011. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for itraconazole, filing since 2001. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for itraconazole, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for itraconazole, filing since 2004. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for itraconazole, filing since 2013. Its GMP is recognised in 1 market.
Holds one valid CEP for itraconazole, filing since 2022.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Itraconazole manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free